QA: Nanoviricides INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001379006_2018_Nanoviricides_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001379006, Nanoviricides INC

  xvar xval
0 AssetsCurrent 15,289,627
1 IntangibleAssetsNetIncludingGoodwill 383,198
2 PropertyPlantAndEquipmentNet 11,271,060
3 remainder_Assets 58,929
4 LiabilitiesCurrent 4,665,518
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 2,015,354
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,046,001
9 ResearchAndDevelopmentExpense 5,488,401
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -1,183,532
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 27,002,814
1 Liabilities 6,680,872
2 Expenses 9,534,402
3 Revenues 0
4 StockholdersEquity 20,321,942
5 NetIncome -10,717,934
6 ComprehensiveNetIncome -10,717,934
7 BaseVar 22,200,810
8 EconomicCapitalRatiobeforeLimitedLiability 1.99
9 EconomicCapitalRatio 3.02

Edgar->Model Mapping

Feature Distribution

Change over Time